Filing Flows › Alpha Teknova (TKNO) › Q2 2025
Alpha Teknova (TKNO) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 8, 2025
Alpha Teknova (TKNO) reported revenue of $10.3M for the second quarter 2025 (Q2 2025), +7% from a year earlier and +5% from the quarter before. Operating margin was -32.9%, net loss $3.6M (34.7% of revenue).
Alpha Teknova, Q2 2025: revenue $10.3M (+7% year over year), operating margin -32.9%, net loss $3.6M, operating cash flow −$2.1M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.3M | +5% | +7% |
| Operating profit | −$3.4M | — | — |
| Net earnings | −$3.6M | — | — |
| Operating cash flow | −$2.1M | — | — |
What changed
Revenue was $10.3M in Q2 2025, up 7% year over year and up 5% from the previous quarter. Lab Essentials was the largest line at 76% of revenue. Clinical Solutions added $495K year over year (up 32%), 74% of the total change.
Gross margin was 38.7%, up 9.6 points from a year earlier. Operating costs exceeded revenue by $3.4M, an operating margin of -32.9%. Operating expenses fell 7% while revenue rose 7%. The quarter ended with a net loss of $3.6M, narrower than the previous quarter's $4.6M loss.
Operating cash flow was −$2.1M. Non-cash charges added back $1.6M of depreciation and amortization and $0.9M of share-based compensation. Working capital and other items used $1.1M. Capital expenditures of $207K exceeded it, leaving free cash flow of −$2.3M.
Questions
What was Alpha Teknova's revenue in the second quarter 2025?
Alpha Teknova (TKNO) reported revenue of $10.3M for the second quarter 2025 (Q2 2025), +7% from a year earlier and +5% from the quarter before.
Was Alpha Teknova profitable in the second quarter 2025?
Operating loss was $3.4M (-32.9% of revenue) and net loss $3.6M.
Source: Alpha Teknova 10-Q on SEC EDGAR.